Tandem Diabetes Care, Inc. ist eine Aktie aus dem Premium-Bereich von aktien.guide. Bitte anmelden, um einen Alarm für Tandem Diabetes Care, Inc. zu aktivieren.
Kostenlos registrieren
Bitte registriere Dich kostenlos, um Tandem Diabetes Care, Inc. zu Deinem Portfolio hinzuzufügen.
Tandem Diabetes Care beat earnings -- but only by losing less money than expected -- on Thursday. On the plus side, sales jumped much higher than expected.
Tandem Diabetes Care, Inc. (NASDAQ:TNDM ) Q1 2024 Earnings Conference Call May 2, 2024 4:30 PM ET Company Participants Susan Morrison - Executive Vice President and Chief Administrative Officer. John Sheridan - President and Chief Executive Officer Leigh Vosseller - Executive Vice President and Chief Financial Officer Conference Call Participants Steve Lichtman - Oppenheimer Brooks O'Neil - Lak...
SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a global insulin delivery and diabetes technology company, today reported its financial results for the quarter ended March 31, 2024 and increased sales guidance for the year ending December 31, 2024. First Quarter 2024 Highlights Compared to First Quarter 2023: Worldwide GAAP sales increased 13 percent to $191.7 million; wo...
SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that management will present a company update at the following investor conferences: BofA Securities Health Care Conference 2024 on Wednesday, May 15, 2024 at 1:00pm Eastern Time (10:00am Pacific Time), and Leerink Partners Healthcare Crossroads Conf...
SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, plans to release its first quarter 2024 results after the financial markets close on Thursday, May 2, 2024. The Company will hold a conference call and simultaneous webcast on the same day at 4:30 pm Eastern Time (1:30 pm Pacific Time), to discuss its first quarter ...
Tandem Diabetes Care is facing economic issues affecting its financial results. The company has the tools to bounce back, including a recently launched device.
aktien.guide ist das Tool zum einfachen Finden, Analysieren und Beobachten von Aktien. Lerne von erfolgreichen Investoren und triff fundierte Anlageentscheidungen. Wir machen Dich zum selbstbestimmten Investor.